HIGH-DOSE CISPLATIN AND BLEOMYCIN NEOADJUVANT CHEMOTHERAPY PLUS RADICAL SURGERY IN LOCALLY ADVANCED CERVICAL-CARCINOMA - A PRELIMINARY-REPORT
HIGH-DOSE CISPLATIN AND BLEOMYCIN NEOADJUVANT CHEMOTHERAPY PLUS RADICAL SURGERY IN LOCALLY ADVANCED CERVICAL-CARCINOMA - A PRELIMINARY-REPORT
复制标题
DOI:
10.1016/0090-8258(91)90310-2
复制
发表时间:
1991-06-01
影响因子:
4.7
通讯作者:
MANCUSO, S
中科院分区:
文献类型:
--
作者:
PANICI, PB;GREGGI, S;MANCUSO, S
One course of chemotherapy containing cisplatin and bleomycin as a neoadjuvant treatment was given to 26 consecutive patients with previously untreated stage IB (bulky disease)-III cervical carcinoma and followed by radical surgery. After chemotherapy responses were detected in 23 patients (5 complete and 18 partial; overall, 88%) and permitted radical surgery in 21 cases (81%). Surgery consisted of type III–IV radical hysterectomy plus systematic para-aortic and pelvic lymphadenectomy. At histologic examination, complete responses were found in 5 (19%) and partial responses in 16 (62%) cases. The average number of lymph nodes removed was 61 (range, 38–118). A lower than expected incidence of lymph node metastases was detected (2 21, 9.5%). The chemotherapy-induced toxicity was mainly represented by nausea and vomiting. Chemotherapy did not seem to complicate surgery in these circumstances, even though moderate-degree postoperative complications occurred in 48% of cases. Eighteen months median follow-up time (range, 11–23) from hystological diagnosis has been reached in the operated patients, and no recurrences have been detected so far.